Cargando…

Ceftriaxone/doxycycline/immunosuppressants: Disseminated histoplasmosis following an off label use and lack of efficacy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897076/ http://dx.doi.org/10.1007/s40278-022-10907-8

Ejemplares similares

Ceftriaxone/dexamethasone/levofloxacin: Lack of efficacy following off-label use: case report
Publicado: (2022)

Ceftriaxone/hydroxychloroquine/lopinavir: Lack of efficacy in off-label use: case report
Publicado: (2021)

Ceftriaxone/favipiravir/vancomycin: Lack of efficacy and off-label use: case report
Publicado: (2022)

Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Ceftriaxone/cobicistat/darunavir/hydroxychloroquine: Off-label use and lack of efficacy: case report
Publicado: (2022)

Ceftriaxone: Cholelithiasis following off-label use: case report
Publicado: (2021)

Ceftriaxone: Lack of efficacy: case report
Publicado: (2022)

Abatacept/immunosuppressants/ruxolitinib: Various toxicities following off-label use and lack of efficacy: 20 case reports
Publicado: (2022)

Corticosteroids/immunosuppressants/steroids: COVID-19 and lack of efficacy following off label use: 7 case reports
Publicado: (2022)

Multiple drugs: Off-label use, lack of efficacy and acquired immunosuppression syndrome: case report
Publicado: (2022)

Dexamethasone: Acute pulmonary histoplasmosis following Off-label use: case report
Publicado: (2021)

Ceftriaxone and Doxycycline induced Seroconversion in Previously Seronegative Patient with Clinically Suspected Disseminated Lyme Disease: Case Report
por: Zagorac, Gordana Blagojević, et al.
Publicado: (2021)

Favipiravir: Lack of efficacy following off-label treatment: case report
Publicado: (2021)

Methylprednisolone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Eculizumab: Lack of efficacy following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Lack of efficacy following an off-label use: case report
Publicado: (2021)

Tocilizumab: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Ceftriaxone/dopamine/vancomycin: Lack of efficacy: case report
Publicado: (2021)

Ceftriaxone/doxycycline: Mucormycosis and Rhizopus infection: 2 case reports
Publicado: (2022)

Immunosuppressants/azithromycin: Prolonged COVID-19 infection, off label use and lack of efficacy: case report
Publicado: (2021)

Ceftriaxone/levofloxacin/lopinavir/ritonavir: Thrombocytopenia following off-label use: case report
Publicado: (2021)

Multiple drugs: Lack off efficacy following off-label use: 2 case reports
Publicado: (2022)

Moxifloxacin/umifenovir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Multiple drugs: Off-label use followed by lack of efficacy: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2022)

Various drugs: Lack of efficacy following an off-label use: case report
Publicado: (2021)

Cefuroxime/oseltamivir: Lack of efficacy following off label use: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy following an off label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Lack of efficacy following off-label therapy: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy following off label use: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy following off-label use: case report
Publicado: (2022)

Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Publicado: (2020)

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Azithromycin: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Empyema Secondary to Actinomyces meyeri Treated Successfully with Ceftriaxone Followed by Doxycycline
por: Paris, Etienne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l5ecror00n5prvuk21fp84q8fj